Skip to content

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Thailand

DiabCare Asia 2008. A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Diabetic Patients in Asia and To Evaluate Perceptions and Practices of Physicians and Patients About Diabetes Management in Asia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00805922
Acronym
DiabCare Asia
Enrollment
2342
Registered
2008-12-10
Start date
2008-12-31
Completion date
2009-09-30
Last updated
2016-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

Brief summary

This study is conducted in Asia. The aim of this observational study is to evaluate current status of diabetes management, control, complications in diabetic subjects in Thailand.

Interventions

OTHERNo treatment given

Capillary or venous blood will be drawn for analysing HbA1c.

Sponsors

Novo Nordisk A/S
Lead SponsorINDUSTRY

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Diabetic patients registered in the particular centre for more than 12 months. * Patients should have visited the centre at least once in the last 3-6 months apart from the initial visit. * Patients willing to sign informed consent form.

Exclusion criteria

* Repetition of any patient as patients should not be included twice for any reason. * Unwilling to participate or unable to comply with protocol requirements.

Design outcomes

Primary

MeasureTime frame
Mean blood glucose parameters of diabetic patientsStudy start

Secondary

MeasureTime frame
Patients' perception will be analysed through patient questionnaire measuring psychological well-being, quality of life and patients' compliant to treatmentStudy start
Physician perception of diabetes and its management will be analysed through physician questionnaire measuring awareness about HbA1c test and its goal, anti-diabetic treatment and barriers towards optimum diabetes controlStudy start
Duration of diabetes associated with highest number of diabetic complicationsStudy start
Minimum duration of diabetes associated with 10% incidence of diabetic complications (CVD, Nephropathy and retinopathy)Study start

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026